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It is also the most common malignancy presented to Cipto Mangunkusumo Hospital. We had 219 cases of osteosarcoma from 1995 to 2008 (16.8 cases/year), and more than 90% cases came with stage IIB.
Before the 1970s, management routinely consisted of transbone amputations or disarticulations, with survival rates of 10% to 20%. 2 The treatment and prognosis of osteosarcoma have changed dramatically since adjuvant chemotherapy began to be used in the early l970s.
3-7 Radical ablative surgery has been largely abandoned in favour of limb salvage by procedures consisting of en bloc resection of the tumor and reconstruction with a prosthesis, an allograft or a bridging technique, as introduced by Juvara. 4 Computed tomography and magnetic resonance imaging (MRI) allow the precise visualization of the anatomic location of a tumor and its relation to surrounding structures. 2, 8 Preoperative planning has been advanced through the use of these modalities, fostering better patient selection for specifi c treatment strategies and lowering the morbidity rates of biopsy and subsequent resection. 8, 9 Multimodality therapy has increased long-term survival rates of patients with chemotherapy-sensitive tumors from 5% to 10% 20 years ago to 60% to 75% most recently. 6, 10, 11 Currently, we are able to choose from a variety of methods of reconstruction, including osteoarticular allografts, intercalary allografts, allograft-prosthetic composites, arthrodesis with autogenous or allogenic bone, custom made prostheses, and rotationalplasty. 2, [12] [13] [14] Thus, since 1995, we have used an alternative technique, namely en bloc resection of the tumor, extracorporeal irradiation (ECI) and re-implantation of the resected bone. This procedure was fi rst described by Uyttendaele et al. in 1988. 15 It has several theoretical advantages, including the preservation of the range of movement of a joint, restoration of the normal mass of bone, and avoidance of early and late loosening and breakage of a massive prosthesis. 7, 15 It is a very useful procedure regarding limitation of obtaining allograft or endoprosthesis in our center. We now evaluate the outcomes of 20 patients with osteosarcoma stage IIB treated by this procedure during 1995-2008.
METHODS
We have evaluated the outcomes of 20 stage IIB osteosarcoma patients treated by en bloc resection, ECI and re-implantation of the irradiated bone from 1995 to 2008.
Patient characteristics are given in Table 1 . Survival, local recurrence, metastases, complications, union time and functional score based on Musculoskeletal Tumor Society Scoring System -(MSTS) were evaluated from 1 to 84 months follow up. Survival was measured since patients underwent the operation (ECI) until the time of follow up or death. Local recurrence was defi ned by physical, radiologic, and histophatologic examination from the time it occurred since the operation. Metastasis was found by chest X-Ray, CT scan thorax, or bone scan. Complications that we observed were infection, fracture, graft resorption, limb shortening and joint instability. Union time was defi ned with the appearance of bridging callus on the X-ray. Functional status was measured by Musculoskeletal Tumor Society Scoring System (MSTS).
Operative technique
After en-bloc resection, the segment is wrapped in the wet sterile drapes and sterile plastic bags. The resected segment than placed in a box fi lled with dry ice. The packet is delivered for irradiation in National Nuclear Institute (BATAN). Meanwhile, the operative site is prepared for re-implantation on the next day. On return the bone segment is removed from the plastic bag and soaked in warm antibiotic solution. Before adding antibiotic, we took sample water where the graft soaked for culture. It is cleared of unnecessary soft tissue leaving important muscle insertions for re-attachment and then re-implanted.
Extracorporeal irradiation
Irradiation was performed in National Nuclear Institute by 300 Gy in -80 0 C. Transport and irradiation took more than two hours, during which the remaining bone was prepared for repair. Except for the joint capsule and ligament, the soft tissues and the bulk of the tumor were removed from the heavily irradiated resection specimen, but part of the tumor was always left in place, so that some dead tumor cells would be available to help stimulate the patients' immunological system, if indeed this was relevant. Reimplantation and fi xation were performed in the next day. Postoperatively, immobilisation in plaster cast or an orthosis was continued until there was radiographic evidence of bony union. For a tumor in the lower limb, weightbearing was prohibited for approximately one year because of the time needed for the vascularization and remodeling of a massive autograft. This would depend on the size and anatomical location of the graft, but will be at least six months, and may never be complete. Samples of bone taken at reoperation, one year or more later, showed that there was partial replacement by new bone and fresh fi brous tissue but the framework of dead bone was also present.
Statistics analysis
Kaplan-Meier method was used to describe survival, local recurrence free survival, metastases free survival. The correlation with patient's characteristics that were age, gender, duration, site of tumor size, type of osteosarcoma, SAP (serum alkaline phosphatase) level, type of biopsy, and type of Huvos were analyzed by Log rank test. Chi-square test was used to analyze the correlation between MSTS score and patient's characteristics, local recurrence, metastases, complications.
RESULTS
The mean follow up was 26 months (1 to 84 months) measured from the date of surgery. The results are summarized in Table 2 . Of the 20 patients, 11 patients (55%) were free of disease, three patients (15%) were loss of follow up and six patients (30%) died. Five from six patients died due to lung metastases, and one patient died due to complication of chemotherapy.
Five year survival of 20 patients was 54, 97 ± 9, 8 % (95%CI, 35, [72] [73] [74] 21) . There was no signifi cant correlation between survival and patients' characteristics, however trend of Kaplan-Meier curve formed by size of the tumor and the Huvos had a constant pattern. It was showed that tumor size more than 10 cm in diameter always had better survival than tumor size less than 10 cm. Good type of Huvos (III&IV) always had better 
Local Recurrence
Four patients (20%) had local recurrence and three of them underwent above knee amputation. One patient also developed lung metastases.
Five years local recurrence free survival was 66.5 ± 7.6% (95% CI, 51.6%-81.7%). There was signifi cant correlation between local recurrence free survival and tumor size (p=0.036), but there was no correlation with other patients characteristics (p>0.005). Curve that formed by SAP and Huvos had constant pattern. It tended to have signifi cant correlation. Increased SAP had higher local recurrence. Poor type of Huvos had higher local recurrence.
Metastases
Metastases occurred in fi ve patients (25%), one patient also developed local recurrence. All of them died (p=0.000). Five year metastasis free survival 57.13 ± 10.04% (95%CI, 37.45 -76.82%). There was no correlation between metastases and patient's characteristics. However, curves formed by tumor size and type of Huvos showed that they tend to be signifi cantly correlated. Size of more than 10 cm had higher metastases. Poor type of Huvos had higher metastases.
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Complications
Five patients had infection (25%); three of them also developed local recurrence, two of them underwent amputation, while one patient refused. Two patients had lung metastases and died, one of them also developed local recurrence. This patient had partial skin necrosis and was locally fl apped and died.
Two of fi ve had debridement, one of them had undergone bone transport by Ilizarov method. These two patients could be relieved from infection. One of fi ve had bone resorption and was planned to use an allograft.
Two patients had graft fracture and had undergone revision with graft/cement augmentation. Limb shortening of 2 cm occured in one patient that had been operated in 12 years of age. Knee instability occurred in all patients with tumor around knee.
Another complications caused by side effect of adjuvant chemotherapy occurred in one patient (5%). The patient developed leucopenia and died. 
Union Time
Fifteen of twenty patients had union on the reimplanted segment with union time rate 8.13 months (4-12 months). 
MSTS Score
DISCUSSION
Nowadays, limb salvage procedure is prefered to amputation.
2 Neo-adjuvant chemotherapy reduced size of the tumor and, combined with improvement of radiological instruments such as CT scan and MRI, resulted in developing reconstruction technique. Limb salvage was expected to have better function and survival rate than amputation was.
2,16 Extracorporeal irradiation (ECI) autograft is a usefull alternative of limb salvage procedure regarding limitation of endoprostheses and allograft. Bone stock can be maintained and suitable for the patient and can preserve epiphyseal plate in immature patient. 17, 18 From 1995 to 2008, 20 patients with stage IIB osteosarcoma underwent limb salvage procedure by ECI. The outcomes showed similar characteristics with previous studies.
Survival
Five year survival rate was 54.97 ± 9.8 %. This was similar to those of other studies (40-70%), and not too different with that of amputation (68,5%). 19 This survival had no correlation with patient's characteristics. Kaplan Meier curve formed by tumor size and Huvos showed constant pattern. Patients with tumor size < 10 cm in diameter and good type of Huvos always had better survival than tumor size > 10 cm in diameter and poor type of Huvos. It could be proven with larger sample of patients. Huvos et al. reported that the survival rate of patients with tumor cell necrosis of more than 90% following neoadjuvant chemotherapy was 80-90%, and the survival rate of those with cell tumor nerosis of less than 90% was 15%. 20 These survival rates showed statistically strong correlation with metastases (p=0.0001). All patients with lung metastases (4 patients) died. In the previous report, 80-90% patients with osteosarcoma died, even those who had already undergone ablative procedure. Micrometastases had developed in most cases.
21, 22
Local reccurence
We had four patients (20%) with local recurrence. All of them had tumor size > 10 cm diameter. In previous studies local recurrence developed in 5-10% patients that performed marginal excision.
23 All of our patients underwent wide excision, but it was probable that not all of them had their tumors adequately excised.
Five-year local recurrence free survival was 66.5 ± 7.6%. There was signifi cant correlation between local recurrence and tumor size (p=0.036). In other studies, tumor size had become prognostic factor that infl uence local recurrence. 55 % our patients had tumor size > 10 cm in diameter. So the result was inferior to that of other studies (85-90%) . 23 This local recurrence free survival had no correlation with other patient's characteristics (p>0,005). The curve formed by SAP and Huvos showed constant pattern. Patients with normal level of SAP and good type of Huvos always had better local recurrence free survival than increased SAP and poor type of Huvos. It could be proven with larger sample of patients. Bacci et al, showed that risk of recurrence increased with increasing SAP, inadequate surgical margin and poor response to neoadjuvant chemotherapy.
4,23,24 SAP had been used to monitor bone malignancy in which the level increased in bone forming tumor. However SAP level also increased in liver metastases. More spesifi c indicator was bone specifi c alkaline phosphatase (BSAP), but still not available in our center.
24
Metastases
Lung metastases developed in fi ve patients (25%), all of them also had local recurrence. All of fi ve died (p=0.000). This result similar with previous studies. More than 90% of patients with osteosarcoma with lung metastases died even when ablative procedure had been performed. Most of cases had had micrometastases before diagnosis was established. Risk factors for metastases were inadequate excision, poor response to neoadjuvant chemotherapy (Huvos I, II) and inadequate adjuvant chemotherapy.
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Five-year metastases-free survival was 57.13 ± 10.04%. The result was not different from other studies (70%).
There was no signifi cant correlation between metastases and patient's characteristics (p>0.05). Kaplan-Meier curve formed by tumor size and type of Huvos had constant pattern. Patients with tumor size <10 cm and good type of Huvos always had better metastasis free survival.
Tumor size, increased level of SAP dan Huvos could be predictive factors that infl uenced survival, local recurrence and metastases.
Complications
We evaluated infections, graft fracture, bone resorption, limb shortening, joint instability and complication caused by side effect of chemotherapy. Several operative procedures had been performed to overcome these conditions. Infection occurred in fi ve patients (20%). Amputation was performed in two of three patients that also developed local recurrence. One patient had partial skin necrosis and was managed by debridement and local fl ap. Two of fi ve underwent debridement and one of them used Ilizarov technique for bone transport. They were relieved from infections. One of fi ve that had proximal humerus tumor also developed bone resorption and was planned for further procedure using allograft. Infections could be minimized by proper pre-operative planning, adequate antibiotic and good handling in operative procedure. A study from Davidson AW et al, reported 4 % bone resorption occurred at proximal humerus. It could be caused by far revascularization distance. Knee instability always occurred in patients with tumor around the knee. This condition could be tolerated by patients and did not interfere with daily activity. In other studies it was also reported that knee instability developed in most cases of tumor around the knee. One patient had another complication caused by side effect of adjuvant chemotherapy (leucopenia). Deaths following chemotherapy administration have been reported by some studies. But there was still not enough evidence that the death was caused by chemotherapy.
2
Union Time
Union occurred in fi fteen of twenty patients with union time rate of 8.13 months (4-12 months). This was not too different with previous report (6-8 months), with full weight bearing in month 12. 4, 25 Remodelling was very limited and suggested that exchange by vital bone would not occur. There was always part of dead bone and fi brous tissue. 2, 5, 25 
MSTS score
All patients with no evidence of disease (NED) had good MSTS score rate (70.63%). This result was similar with other studies (68%). Patients with complications had poor score rate (41.63%), combined with 57% in other studies. 5, 26 Functional score was signifi cantly correlated with local recurrence (p=0.025), metastases (p=0.011), complication (p=0.03), combinations with local recurrence + metastases (p=0.000) ( Table 3) . Functional result in patients with NED also depended on rehabilitation program postoperatively.
It can be concluded that the outcomes of 20 stage IIB osteosarcoma patients treated by ECI in our center were good. The procedure could be useful alternative of limb salvage procedure in treating stage IIB osteosarcoma regarding limitation of endoprosthesis and allograft. Tumor size, SAP level, and type of Huvos could be perdictive factors that infl uenced prognosis in osteosarcoma stage IIB treated by ECI. This study should be continued with larger sample to have a statistically signifi cant result.
